In agreement with previous studies, immunohistochemistry of a human GBM specimen demonstrated strong immunoreactivity for FOXM1 in the nuclei of GBM cells (Supporting Information Fig. S4) [35]. This evidence concerns the gene FOXM1 and glioblastoma.